GU Cancers 2019 | Key updates on testicular cancer management

Robert Huddart

Robert Huddart, MBBS, MRCP, FRCR, PhD, of The Institute of Cancer Research and the Royal Marsden NHS Foundation Trust, London, UK, reviews important updates on testicular cancer management, including the value of micro-RNA as biomarkers in testicular cancer prognosis, and the use of adjuvant chemotherapy for treating non-seminomatous testicular tumors. This video was recorded at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.

Share this video